Photo by ryanancill from unsplash
Key Points Proteomic profiling identifies downregulated CLU expression as potential driver of myeloid hyperproliferation in PV. We detect LGALS9 and SOCS2 protein expression in HSC/MPPs as possible markers for progressed… Click to show full abstract
Key Points Proteomic profiling identifies downregulated CLU expression as potential driver of myeloid hyperproliferation in PV. We detect LGALS9 and SOCS2 protein expression in HSC/MPPs as possible markers for progressed PV.
Keywords:
progression markers;
proliferation progression;
proteomic identification;
identification proliferation;
markers human;
human polycythemia
Journal Title: Blood Advances
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Blood Advances
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!